SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-001069
Filing Date
2022-02-16
Accepted
2022-02-16 16:01:21
Documents
13
Period of Report
2022-02-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannapharmarx_8k.htm   iXBRL 8-K 22307
2 PRESS RELEASE cannapharmarx_ex9906.htm EX-99.6 6888
  Complete submission text file 0001683168-22-001069.txt   206414

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cpmd-20220214.xsd EX-101.SCH 3048
4 XBRL LABEL FILE cpmd-20220214_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE cpmd-20220214_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT cannapharmarx_8k_htm.xml XML 3682
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 22643497
SIC: 2834 Pharmaceutical Preparations